Home › Ovarian Cancer › Mississippi › Jackson
Ovarian Cancer clinical trials in Jackson, MS
3 studies for Ovarian Cancer are looking for participants at sites in and around Jackson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RecruitingObservational study
- University of Mississippi Medical Center, Jackson
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RecruitingPhase 2
- University Of Mississippi Medical Center /ID# 276342, Jackson
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RecruitingPhase 2
- University of Mississippi Medical Center, Jackson
About Ovarian Cancer
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
More about Ovarian Cancer on MedlinePlus
Ovarian Cancer trials in other cities
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Other studies in Jackson
- Obesity8 studies
- Overweight6 studies
- Steatotic Liver Disease5 studies
- Breast Cancer5 studies
- Heart Failure5 studies
- Sickle Cell Disease5 studies
- Non-Small Cell Lung Cancer5 studies
- Lung Cancer5 studies
- Type 2 Diabetes5 studies
- Prostate Cancer5 studies
- Burkitt Lymphoma4 studies
- Acute Myeloid Leukemia4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.